Tani Shigemasa, Takahashi Atsuhiko, Nagao Ken, Hirayama Atsushi
Health Planning Center and 2. Division of Cardiology, Department of Medicine, Nihon University School of Medicine.
Int Heart J. 2015 May 13;56(3):260-8. doi: 10.1536/ihj.14-243. Epub 2015 Apr 23.
We investigated the relationships between the ratio of serum n-3 polyunsaturated fatty acids (n-3PUFAs: eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) to n-6PUFA (arachidonic acid [AA]) and the prevalence of coronary artery disease (CAD), and assessed the association of the ratio of serum n-3 to n-6 PUFAs with atherosclerosis-related markers.This study was designed as a hospital-based cross-sectional study of 649 consecutive outpatients who had undergone regular examinations between April 2009 and October 2009. We divided the patients into 5 groups based on the quintiles of the EPA/AA ratio or quintiles of the DHA/AA ratio to determine independent factors for the prevalence of CAD.In multivariate logistic regression analyses after adjustment for coronary risk factors and serum n-3PUFAs levels to minimize confounding factors to the extent possible because the serum levels of EPA and DHA showed a strong correlation (r = 0.812, P < 0.0001), the group with the highest EPA/AA ratio had a lower probability of CAD prevalence (odds ratio: 0.328, 95% confidence interval: 0.113 to 0.956, P = 0.041), but this was not true for the DHA/AA ratio. Multivariate analysis showed an increase in the EPA/AA ratio, but not in the DHA/AA ratio, was associated with effects on atherosclerosis-related markers, especially triglyceride-rich lipoproteins, high-density lipoprotein cholesterol (HDL-C) containing apolipoprotein A-1, and leukocyte count in an anti-atherogenic direction.The results suggest a higher EPA/AA ratio, but not a higher DHA/AA ratio, might be associated with a lower prevalence of CAD and improvements of triglyceride metabolism and HDL metabolism, and systemic inflammation.
我们研究了血清n-3多不饱和脂肪酸(n-3PUFAs:二十碳五烯酸[EPA]和二十二碳六烯酸[DHA])与n-6多不饱和脂肪酸(n-6PUFA:花生四烯酸[AA])的比例与冠状动脉疾病(CAD)患病率之间的关系,并评估了血清n-3与n-6多不饱和脂肪酸比例与动脉粥样硬化相关标志物的关联。本研究设计为一项基于医院的横断面研究,纳入了2009年4月至2009年10月期间连续接受定期检查的649例门诊患者。我们根据EPA/AA比例或DHA/AA比例的五分位数将患者分为5组,以确定CAD患病率的独立因素。在对冠状动脉危险因素和血清n-3PUFAs水平进行调整后的多因素逻辑回归分析中,为尽可能减少混杂因素,因为EPA和DHA的血清水平显示出很强的相关性(r = 0.812,P < 0.0001),EPA/AA比例最高的组CAD患病率较低(优势比:0.328,95%置信区间:0.113至0.956,P = 0.041),但DHA/AA比例并非如此。多因素分析表明,EPA/AA比例的增加而非DHA/AA比例的增加与对动脉粥样硬化相关标志物有影响,特别是富含甘油三酯的脂蛋白、含载脂蛋白A-1的高密度脂蛋白胆固醇(HDL-C)以及白细胞计数,呈抗动脉粥样硬化方向。结果表明,较高的EPA/AA比例而非较高的DHA/AA比例可能与较低的CAD患病率以及甘油三酯代谢、HDL代谢和全身炎症的改善有关。